With the rise of personalized medicine, should individuals be responsible for covering the costs of genetic testing and tailored treatments, or should this be a public health responsibility? What are the ethical implications of either approach?

The rise of personalized medicine has transformed healthcare by offering genetic testing and treatments tailored to an individual’s biological profile. A key debate, however, is whether the costs of these innovations should be borne by individuals or supported through public healthcare systems. If individuals are required to cover the costs, personalized medicine could become available […]